2023 CIHR-ICRH/CCCS Distinguished Lecturer Award in Critical Care Sciences
[November 24, 2023]
Dr. Jamie Hutchison has led and collaborated on multiple high-impact studies of molecular mechanisms, clinical translational biology studies and clinical trials focused on critical illness. These include studies of cardiac arrest, traumatic brain injury, transfusion medicine and septic shock. The current goal of Dr. Hutchison’s research program is to improve survival and quality of life among survivors of acquired brain injuries. He has been awarded 69 peer-reviewed research grants over his career, 24 as principal investigator (PI) and 45 as a co-investigator (Co-I), with more than $16 million as PI or Co-PI and more than $120 million as a Co-I. He has published 113 Peer-Reviewed articles and has had multiple visiting professorships and presentations at national and international academic hospitals and meetings. He is the Past-Chair of the Canadian Critical Care Translational Biology Group (CCCTBG), the current Co-chair, with Dr. Alexis Turgeon, of the Canadian Traumatic Brain Injury Research Consortium (CTRC), funded by CIHR, and a member of the International Initiative for Traumatic Brain Injury Research. He has trained more than 20 graduate students and post-doctoral research fellows in his laboratory and mentored multiple pediatric critical care trainees in research. He also helped start and lead highly successful research trainee programs for the Canadian Critical Care Trials Group, the CCCTBG and the CTRC. He is advocating to designate moderate to severe TBI as a chronic condition in Canada on behalf of patients and their families, the CTRC and Brain Injury Canada.
